TY - CHAP AU - Chan, J. K. C. AU - Quintanilla-Martinez, L. AU - Ferry, J. A. ED - Swerdlow, S. H. ED - Campo, E. ED - Harris, N. L. ED - Jaffe, E. S. ED - Pileri, S. A. ED - Stein, H. PY - 2017 DA - 2017// TI - Extranodal NK/T-cell lymphoma, nasal type BT - WHO classification of tumours of haematopoietic and lymphoid tissues PB - International Agency for Research on Cancer CY - Lyon ID - Chan2017 ER - TY - JOUR AU - Ng, S. B. AU - Khoury, J. D. PY - 2009 DA - 2009// TI - Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist JO - Adv Anat Pathol VL - 16 UR - https://doi.org/10.1097/PAP.0b013e3181916029 DO - 10.1097/PAP.0b013e3181916029 ID - Ng2009 ER - TY - JOUR AU - Ng, S. B. AU - Chung, T. H. AU - Kato, S. AU - Nakamura, S. AU - Takahashi, E. AU - Ko, Y. H. PY - 2018 DA - 2018// TI - Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes JO - Haematologica. VL - 103 UR - https://doi.org/10.3324/haematol.2017.180430 DO - 10.3324/haematol.2017.180430 ID - Ng2018 ER - TY - JOUR AU - Lemonnier, F. AU - Gaulard, P. AU - Leval, L. PY - 2018 DA - 2018// TI - New insights in the pathogenesis of T-cell lymphomas JO - Curr Opin Oncol VL - 30 ID - Lemonnier2018 ER - TY - JOUR AU - Huang, Y. AU - Reynies, A. AU - Leval, L. AU - Ghazi, B. AU - Martin-Garcia, N. AU - Travert, M. PY - 2010 DA - 2010// TI - Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type JO - Blood. VL - 115 UR - https://doi.org/10.1182/blood-2009-05-221275 DO - 10.1182/blood-2009-05-221275 ID - Huang2010 ER - TY - JOUR AU - Iqbal, J. AU - Weisenburger, D. D. AU - Chowdhury, A. AU - Tsai, M. Y. AU - Srivastava, G. AU - Greiner, T. C. PY - 2011 DA - 2011// TI - Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase a inhibitor in vitro JO - Leukemia. VL - 25 UR - https://doi.org/10.1038/leu.2010.255 DO - 10.1038/leu.2010.255 ID - Iqbal2011 ER - TY - JOUR AU - Ng, S. B. AU - Selvarajan, V. AU - Huang, G. AU - Zhou, J. AU - Feldman, A. L. AU - Law, M. PY - 2011 DA - 2011// TI - Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling JO - J Pathol VL - 223 UR - https://doi.org/10.1002/path.2823 DO - 10.1002/path.2823 ID - Ng2011 ER - TY - JOUR AU - Kawano, Y. AU - Iwata, S. AU - Kawada, J. AU - Gotoh, K. AU - Suzuki, M. AU - Torii, Y. PY - 2013 DA - 2013// TI - Plasma viral MicroRNA profiles reveal potential biomarkers for chronic active Epstein–Barr virus infection JO - J Infect Dis VL - 208 UR - https://doi.org/10.1093/infdis/jit222 DO - 10.1093/infdis/jit222 ID - Kawano2013 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell. VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Gajewski, T. F. AU - Schreiber, H. AU - Fu, Y. X. PY - 2013 DA - 2013// TI - Innate and adaptive immune cells in the tumor microenvironment JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2703 DO - 10.1038/ni.2703 ID - Gajewski2013 ER - TY - JOUR AU - Kwong, Y. L. AU - Chan, T. S. Y. AU - Tan, D. AU - Kim, S. J. AU - Poon, L. M. AU - Mow, B. PY - 2017 DA - 2017// TI - PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase JO - Blood. VL - 129 UR - https://doi.org/10.1182/blood-2016-12-756841 DO - 10.1182/blood-2016-12-756841 ID - Kwong2017 ER - TY - JOUR AU - Bouchekioua, A. AU - Scourzic, L. AU - Wever, O. AU - Zhang, Y. AU - Cervera, P. AU - Aline-Fardin, A. PY - 2014 DA - 2014// TI - JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma JO - Leukemia. VL - 28 UR - https://doi.org/10.1038/leu.2013.157 DO - 10.1038/leu.2013.157 ID - Bouchekioua2014 ER - TY - JOUR AU - Coppo, P. AU - Gouilleux-Gruart, V. AU - Huang, Y. AU - Bouhlal, H. AU - Bouamar, H. AU - Bouchet, S. PY - 2009 DA - 2009// TI - STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma JO - Leukemia. VL - 23 UR - https://doi.org/10.1038/leu.2009.91 DO - 10.1038/leu.2009.91 ID - Coppo2009 ER - TY - JOUR AU - Lee, S. AU - Park, H. Y. AU - Kang, S. Y. AU - Kim, S. J. AU - Hwang, J. AU - Lee, S. PY - 2015 DA - 2015// TI - Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.3776 DO - 10.18632/oncotarget.3776 ID - Lee2015 ER - TY - JOUR AU - Kimura, H. AU - Karube, K. AU - Ito, Y. AU - Hirano, K. AU - Suzuki, M. AU - Iwata, S. PY - 2014 DA - 2014// TI - Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan JO - Leukemia Lymphoma VL - 55 UR - https://doi.org/10.3109/10428194.2013.819577 DO - 10.3109/10428194.2013.819577 ID - Kimura2014 ER - TY - JOUR AU - Koo, G. C. AU - Tan, S. Y. AU - Tang, T. AU - Poon, S. L. AU - Allen, G. E. AU - Tan, L. PY - 2012 DA - 2012// TI - Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0028 DO - 10.1158/2159-8290.CD-12-0028 ID - Koo2012 ER - TY - JOUR AU - Guo, Y. AU - Arakawa, F. AU - Miyoshi, H. AU - Niino, D. AU - Kawano, R. AU - Ohshima, K. PY - 2014 DA - 2014// TI - Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma JO - Pathol Int VL - 64 UR - https://doi.org/10.1111/pin.12166 DO - 10.1111/pin.12166 ID - Guo2014 ER - TY - JOUR AU - Jiang, L. AU - Gu, Z. H. AU - Yan, Z. X. AU - Zhao, X. AU - Xie, Y. Y. AU - Zhang, Z. G. PY - 2015 DA - 2015// TI - Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3358 DO - 10.1038/ng.3358 ID - Jiang2015 ER - TY - JOUR AU - Sim, S. H. AU - Kim, S. AU - Kim, T. M. AU - Jeon, Y. K. AU - Nam, S. J. AU - Ahn, Y. O. PY - 2017 DA - 2017// TI - Novel JAK3-activating mutations in Extranodal NK/T-cell lymphoma, nasal type JO - Am J Pathol VL - 187 UR - https://doi.org/10.1016/j.ajpath.2017.01.004 DO - 10.1016/j.ajpath.2017.01.004 ID - Sim2017 ER - TY - JOUR AU - Kucuk, C. AU - Jiang, B. AU - Hu, X. AU - Zhang, W. AU - Chan, J. K. AU - Xiao, W. PY - 2015 DA - 2015// TI - Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms7025 DO - 10.1038/ncomms7025 ID - Kucuk2015 ER - TY - JOUR AU - Chen, Y. W. AU - Guo, T. AU - Shen, L. AU - Wong, K. Y. AU - Tao, Q. AU - Choi, W. W. PY - 2015 DA - 2015// TI - Receptor-type tyrosine-protein phosphatase kappa directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma JO - Blood. VL - 125 UR - https://doi.org/10.1182/blood-2014-07-588970 DO - 10.1182/blood-2014-07-588970 ID - Chen2015 ER - TY - JOUR AU - Murakami, M. AU - Hashida, Y. AU - Imajoh, M. AU - Maeda, A. AU - Kamioka, M. AU - Senda, Y. PY - 2014 DA - 2014// TI - PCR array analysis of gene expression profiles in chronic active Epstein-Barr virus infection JO - Microbes Infect VL - 16 UR - https://doi.org/10.1016/j.micinf.2014.04.004 DO - 10.1016/j.micinf.2014.04.004 ID - Murakami2014 ER - TY - JOUR AU - Hu, X. AU - Ivashkiv, L. B. PY - 2009 DA - 2009// TI - Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases JO - Immunity. VL - 31 UR - https://doi.org/10.1016/j.immuni.2009.09.002 DO - 10.1016/j.immuni.2009.09.002 ID - Hu2009 ER - TY - JOUR AU - Nairismagi, M. AU - Gerritsen, M. E. AU - Li, Z. M. AU - Wijaya, G. C. AU - Chia, B. K. H. AU - Laurensia, Y. PY - 2018 DA - 2018// TI - Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma JO - Leukemia. VL - 32 UR - https://doi.org/10.1038/s41375-017-0004-x DO - 10.1038/s41375-017-0004-x ID - Nairismagi2018 ER - TY - JOUR AU - Zhang, Y. AU - Xu, W. AU - Liu, H. AU - Li, J. PY - 2016 DA - 2016// TI - Therapeutic options in peripheral T cell lymphoma JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0267-0 DO - 10.1186/s13045-016-0267-0 ID - Zhang2016 ER - TY - JOUR AU - Bracken, A. P. AU - Dietrich, N. AU - Pasini, D. AU - Hansen, K. H. AU - Helin, K. PY - 2006 DA - 2006// TI - Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions JO - Genes Dev VL - 20 UR - https://doi.org/10.1101/gad.381706 DO - 10.1101/gad.381706 ID - Bracken2006 ER - TY - JOUR AU - Yan, J. AU - Li, B. AU - Lin, B. AU - Lee, P. T. AU - Chung, T. H. AU - Tan, J. PY - 2016 DA - 2016// TI - EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma JO - Blood. VL - 128 UR - https://doi.org/10.1182/blood-2016-01-690701 DO - 10.1182/blood-2016-01-690701 ID - Yan2016 ER - TY - JOUR AU - Yan, J. AU - Ng, S. B. AU - Tay, J. L. AU - Lin, B. AU - Koh, T. L. AU - Tan, J. PY - 2013 DA - 2013// TI - EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity JO - Blood. VL - 121 UR - https://doi.org/10.1182/blood-2012-08-450494 DO - 10.1182/blood-2012-08-450494 ID - Yan2013 ER - TY - JOUR AU - McCabe, M. T. AU - Ott, H. M. AU - Ganji, G. AU - Korenchuk, S. AU - Thompson, C. AU - Aller, G. S. PY - 2012 DA - 2012// TI - EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations JO - Nature. VL - 492 UR - https://doi.org/10.1038/nature11606 DO - 10.1038/nature11606 ID - McCabe2012 ER - TY - JOUR AU - Hee, Y. T. AU - Yan, J. AU - Nizetic, D. AU - Chng, W. J. PY - 2018 DA - 2018// TI - LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL) JO - Oncotarget. VL - 9 UR - https://doi.org/10.18632/oncotarget.25835 DO - 10.18632/oncotarget.25835 ID - Hee2018 ER - TY - JOUR AU - Jost, P. J. AU - Ruland, J. PY - 2007 DA - 2007// TI - Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications JO - Blood. VL - 109 ID - Jost2007 ER - TY - JOUR AU - Liu, X. AU - Wang, B. AU - Ma, X. AU - Guo, Y. PY - 2009 DA - 2009// TI - NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type JO - Jpn J Clin Oncol VL - 39 UR - https://doi.org/10.1093/jjco/hyp037 DO - 10.1093/jjco/hyp037 ID - Liu2009 ER - TY - JOUR AU - Wen, H. AU - Ma, H. AU - Cai, Q. AU - Lin, S. AU - Lei, X. AU - He, B. PY - 2018 DA - 2018// TI - Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma JO - Nat Med VL - 24 UR - https://doi.org/10.1038/nm.4456 DO - 10.1038/nm.4456 ID - Wen2018 ER - TY - JOUR AU - Wi, S. M. AU - Moon, G. AU - Kim, J. AU - Kim, S. T. AU - Shim, J. H. AU - Chun, E. PY - 2014 DA - 2014// TI - TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-kappaB JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M114.597187 DO - 10.1074/jbc.M114.597187 ID - Wi2014 ER - TY - JOUR AU - Chen, C. AU - He, H. PY - 2017 DA - 2017// TI - Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine JO - Mol Clin Oncol VL - 7 UR - https://doi.org/10.3892/mco.2017.1364 DO - 10.3892/mco.2017.1364 ID - Chen2017 ER - TY - JOUR AU - Tang, T. AU - Tay, K. AU - Tao, M. AU - Quek, R. H. H. AU - Farid, M. AU - Lim, S. T. PY - 2016 DA - 2016// TI - A Phase II Study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in Patients with Newly Diagnosed Natural-Killer/T-Cell Lymphoma JO - Blood VL - 128 ID - Tang2016 ER - TY - JOUR AU - Yoshida, G. J. PY - 2018 DA - 2018// TI - Emerging roles of Myc in stem cell biology and novel tumor therapies JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0835-y DO - 10.1186/s13046-018-0835-y ID - Yoshida2018 ER - TY - JOUR AU - O'Neil, J. AU - Look, A. T. PY - 2007 DA - 2007// TI - Mechanisms of transcription factor deregulation in lymphoid cell transformation JO - Oncogene. VL - 26 UR - https://doi.org/10.1038/sj.onc.1210766 DO - 10.1038/sj.onc.1210766 ID - O'Neil2007 ER - TY - JOUR AU - Welcker, M. AU - Orian, A. AU - Jin, J. AU - Grim, J. A. AU - Harper, J. W. AU - Eisenman, R. N. PY - 2004 DA - 2004// TI - The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation JO - Proc Natl Acad Sci VL - 101 UR - https://doi.org/10.1073/pnas.0402770101 DO - 10.1073/pnas.0402770101 ID - Welcker2004 ER - TY - JOUR AU - Wang, J. H. AU - Bi, X. W. AU - Li, P. F. AU - Xia, Z. J. AU - Huang, H. Q. AU - Jiang, W. Q. PY - 2017 DA - 2017// TI - Overexpression of MYC and BCL2 predicts poor prognosis in patients with Extranodal NK/T-cell lymphoma, Nasal Type JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.17766 DO - 10.7150/jca.17766 ID - Wang2017 ER - TY - JOUR AU - Ng, S. B. AU - Yan, J. AU - Huang, G. AU - Selvarajan, V. AU - Tay, J. L. AU - Lin, B. PY - 2011 DA - 2011// TI - Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma JO - Blood. VL - 118 UR - https://doi.org/10.1182/blood-2011-07-364224 DO - 10.1182/blood-2011-07-364224 ID - Ng2011 ER - TY - JOUR AU - Chang, T. C. AU - Yu, D. AU - Lee, Y. S. AU - Wentzel, E. A. AU - Arking, D. E. AU - West, K. M. PY - 2008 DA - 2008// TI - Widespread microRNA repression by Myc contributes to tumorigenesis JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.2007.30 DO - 10.1038/ng.2007.30 ID - Chang2008 ER - TY - JOUR AU - Jung, L. A. AU - Gebhardt, A. AU - Koelmel, W. AU - Ade, C. P. AU - Walz, S. AU - Kuper, J. PY - 2017 DA - 2017// TI - OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors JO - Oncogene. VL - 36 UR - https://doi.org/10.1038/onc.2016.354 DO - 10.1038/onc.2016.354 ID - Jung2017 ER - TY - JOUR AU - Selvarajan, V. AU - Osato, M. AU - Nah, G. S. S. AU - Yan, J. AU - Chung, T. H. AU - Voon, D. C. PY - 2017 DA - 2017// TI - RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC JO - Leukemia. VL - 31 UR - https://doi.org/10.1038/leu.2017.40 DO - 10.1038/leu.2017.40 ID - Selvarajan2017 ER - TY - JOUR AU - Cruz-Guilloty, F. AU - Pipkin, M. E. AU - Djuretic, I. M. AU - Levanon, D. AU - Lotem, J. AU - Lichtenheld, M. G. PY - 2009 DA - 2009// TI - Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs JO - J Exp Med VL - 206 UR - https://doi.org/10.1084/jem.20081242 DO - 10.1084/jem.20081242 ID - Cruz-Guilloty2009 ER - TY - JOUR AU - Andrae, J. AU - Gallini, R. AU - Betsholtz, C. PY - 2008 DA - 2008// TI - Role of platelet-derived growth factors in physiology and medicine JO - Genes Dev VL - 22 UR - https://doi.org/10.1101/gad.1653708 DO - 10.1101/gad.1653708 ID - Andrae2008 ER - TY - JOUR AU - Gu, Y. AU - Masiero, M. AU - Banham, A. H. PY - 2016 DA - 2016// TI - Notch signaling: its roles and therapeutic potential in hematological malignancies JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.7772 DO - 10.18632/oncotarget.7772 ID - Gu2016 ER - TY - JOUR AU - Farag, S. S. PY - 2011 DA - 2011// TI - The potential role of Aurora kinase inhibitors in haematological malignancies JO - Br J Haematol VL - 155 UR - https://doi.org/10.1111/j.1365-2141.2011.08898.x DO - 10.1111/j.1365-2141.2011.08898.x ID - Farag2011 ER - TY - JOUR AU - Anand, S. AU - Penrhyn-Lowe, S. AU - Venkitaraman, A. R. PY - 2003 DA - 2003// TI - AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol JO - Cancer Cell VL - 3 UR - https://doi.org/10.1016/S1535-6108(02)00235-0 DO - 10.1016/S1535-6108(02)00235-0 ID - Anand2003 ER - TY - JOUR AU - Dutta-Simmons, J. AU - Zhang, Y. AU - Gorgun, G. AU - Gatt, M. AU - Mani, M. AU - Hideshima, T. PY - 2009 DA - 2009// TI - Aurora kinase a is a target of Wnt/beta-catenin involved in multiple myeloma disease progression JO - Blood. VL - 114 UR - https://doi.org/10.1182/blood-2008-12-194290 DO - 10.1182/blood-2008-12-194290 ID - Dutta-Simmons2009 ER - TY - JOUR AU - Yang, H. AU - Ou, C. C. AU - Feldman, R. I. AU - Nicosia, S. V. AU - Kruk, P. A. AU - Cheng, J. Q. PY - 2004 DA - 2004// TI - Aurora-a kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2907 DO - 10.1158/0008-5472.CAN-03-2907 ID - Yang2004 ER - TY - JOUR AU - Liu, Q. AU - Kaneko, S. AU - Yang, L. AU - Feldman, R. I. AU - Nicosia, S. V. AU - Chen, J. PY - 2004 DA - 2004// TI - Aurora-a abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215 JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M406802200 DO - 10.1074/jbc.M406802200 ID - Liu2004 ER - TY - JOUR AU - Iqbal, J. AU - Kucuk, C. AU - Deleeuw, R. J. AU - Srivastava, G. AU - Tam, W. AU - Geng, H. PY - 2009 DA - 2009// TI - Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies JO - Leukemia. VL - 23 UR - https://doi.org/10.1038/leu.2009.3 DO - 10.1038/leu.2009.3 ID - Iqbal2009 ER - TY - JOUR AU - Fujiwara, S. AU - Kimura, H. AU - Imadome, K. AU - Arai, A. AU - Kodama, E. AU - Morio, T. PY - 2014 DA - 2014// TI - Current research on chronic active Epstein-Barr virus infection in Japan JO - Pediatr Int : official journal of the Japan Pediatric Society VL - 56 UR - https://doi.org/10.1111/ped.12314 DO - 10.1111/ped.12314 ID - Fujiwara2014 ER - TY - JOUR AU - Bartel, D. P. PY - 2009 DA - 2009// TI - MicroRNAs: target recognition and regulatory functions JO - Cell. VL - 136 UR - https://doi.org/10.1016/j.cell.2009.01.002 DO - 10.1016/j.cell.2009.01.002 ID - Bartel2009 ER - TY - JOUR AU - Beaulieu, A. M. AU - Bezman, N. A. AU - Lee, J. E. AU - Matloubian, M. AU - Sun, J. C. AU - Lanier, L. L. PY - 2013 DA - 2013// TI - MicroRNA function in NK-cell biology JO - Immunol Rev VL - 253 UR - https://doi.org/10.1111/imr.12045 DO - 10.1111/imr.12045 ID - Beaulieu2013 ER - TY - JOUR AU - Sullivan, R. P. AU - Leong, J. W. AU - Fehniger, T. A. PY - 2013 DA - 2013// TI - MicroRNA regulation of natural killer cells JO - Front Immunol VL - 4 UR - https://doi.org/10.3389/fimmu.2013.00044 DO - 10.3389/fimmu.2013.00044 ID - Sullivan2013 ER - TY - JOUR AU - Saki, N. AU - Abroun, S. AU - Soleimani, M. AU - Hajizamani, S. AU - Shahjahani, M. AU - Kast, R. E. PY - 2015 DA - 2015// TI - Involvement of MicroRNA in T-cell differentiation and malignancy JO - Int J Hematol Oncol Stem Cell Res VL - 9 ID - Saki2015 ER - TY - JOUR AU - Yamanaka, Y. AU - Tagawa, H. AU - Takahashi, N. AU - Watanabe, A. AU - Guo, Y. M. AU - Iwamoto, K. PY - 2009 DA - 2009// TI - Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia JO - Blood. VL - 114 UR - https://doi.org/10.1182/blood-2009-06-222794 DO - 10.1182/blood-2009-06-222794 ID - Yamanaka2009 ER - TY - JOUR AU - Chang, Y. AU - Cui, M. AU - Fu, X. AU - Zhang, L. AU - Li, X. AU - Li, L. PY - 2019 DA - 2019// TI - MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1 JO - Cancer Biol Ther VL - 20 UR - https://doi.org/10.1080/15384047.2018.1504721 DO - 10.1080/15384047.2018.1504721 ID - Chang2019 ER - TY - JOUR AU - Packham, G. AU - Stevenson, F. K. PY - 2005 DA - 2005// TI - Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia JO - Immunology. VL - 114 UR - https://doi.org/10.1111/j.1365-2567.2005.02117.x DO - 10.1111/j.1365-2567.2005.02117.x ID - Packham2005 ER - TY - JOUR AU - Andersen, M. H. AU - Svane, I. M. AU - Becker, J. C. AU - Straten, P. T. PY - 2007 DA - 2007// TI - The universal character of the tumor-associated antigen survivin JO - Clin Cancer Res : an official journal of the American Association for Cancer Research. VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0686 DO - 10.1158/1078-0432.CCR-07-0686 ID - Andersen2007 ER - TY - JOUR AU - Paydas, S. AU - Ergin, M. AU - Erdogan, S. AU - Seydaoglu, G. AU - Yavuz, S. AU - Disel, U. PY - 2008 DA - 2008// TI - Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas JO - Leuk Res VL - 32 UR - https://doi.org/10.1016/j.leukres.2007.06.024 DO - 10.1016/j.leukres.2007.06.024 ID - Paydas2008 ER - TY - JOUR AU - Raj, D. AU - Liu, T. AU - Samadashwily, G. AU - Li, F. AU - Grossman, D. PY - 2008 DA - 2008// TI - Survivin repression by p53, Rb and E2F2 in normal human melanocytes JO - Carcinogenesis. VL - 29 UR - https://doi.org/10.1093/carcin/bgm219 DO - 10.1093/carcin/bgm219 ID - Raj2008 ER - TY - JOUR AU - Vousden, K. H. AU - Lane, D. P. PY - 2007 DA - 2007// TI - p53 in health and disease JO - Nat Rev Mol Cell Biol VL - 8 UR - https://doi.org/10.1038/nrm2147 DO - 10.1038/nrm2147 ID - Vousden2007 ER - TY - JOUR AU - Quintanilla-Martinez, L. AU - Kremer, M. AU - Keller, G. AU - Nathrath, M. AU - Gamboa-Dominguez, A. AU - Meneses, A. PY - 2001 DA - 2001// TI - p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease JO - Am J Pathol VL - 159 UR - https://doi.org/10.1016/S0002-9440(10)63061-1 DO - 10.1016/S0002-9440(10)63061-1 ID - Quintanilla-Martinez2001 ER - TY - JOUR AU - Schmitt, C. AU - Sako, N. AU - Bagot, M. AU - Huang, Y. AU - Gaulard, P. AU - Bensussan, A. PY - 2011 DA - 2011// TI - Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets JO - J Biomed Biotechnol VL - 2011 UR - https://doi.org/10.1155/2011/790871 DO - 10.1155/2011/790871 ID - Schmitt2011 ER - TY - JOUR AU - Takakuwa, T. AU - Dong, Z. AU - Nakatsuka, S. AU - Kojya, S. AU - Harabuchi, Y. AU - Yang, W. I. PY - 2002 DA - 2002// TI - Frequent mutations of Fas gene in nasal NK/T cell lymphoma JO - Oncogene. VL - 21 UR - https://doi.org/10.1038/sj.onc.1205571 DO - 10.1038/sj.onc.1205571 ID - Takakuwa2002 ER - TY - JOUR AU - Zhang, Y. AU - Li, C. AU - Xue, W. AU - Zhang, M. AU - Li, Z. PY - 2018 DA - 2018// TI - Frequent mutations in natural killer/T cell lymphoma JO - Cell Physiol Biochem : international journal of experimental cellular physiology, biochemistry, and pharmacology VL - 49 UR - https://doi.org/10.1159/000492835 DO - 10.1159/000492835 ID - Zhang2018 ER - TY - JOUR AU - Li, T. AU - Hongyo, T. AU - Syaifudin, M. AU - Nomura, T. AU - Dong, Z. AU - Shingu, N. PY - 2000 DA - 2000// TI - Mutations of the p53 gene in nasal NK/T-cell lymphoma JO - Lab Invest; a journal of technical methods and pathology VL - 80 UR - https://doi.org/10.1038/labinvest.3780055 DO - 10.1038/labinvest.3780055 ID - Li2000 ER - TY - JOUR AU - Takahara, M. AU - Kishibe, K. AU - Bandoh, N. AU - Nonaka, S. AU - Harabuchi, Y. PY - 2004 DA - 2004// TI - P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan JO - Human Pathol VL - 35 UR - https://doi.org/10.1016/j.humpath.2003.08.025 DO - 10.1016/j.humpath.2003.08.025 ID - Takahara2004 ER - TY - JOUR AU - Hongyo, T. AU - Hoshida, Y. AU - Nakatsuka, S. AU - Syaifudin, M. AU - Kojya, S. AU - Yang, W. I. PY - 2005 DA - 2005// TI - p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan JO - Oncol Rep VL - 13 ID - Hongyo2005 ER - TY - JOUR AU - Motsch, N. AU - Alles, J. AU - Imig, J. AU - Zhu, J. AU - Barth, S. AU - Reineke, T. PY - 2012 DA - 2012// TI - MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0042193 DO - 10.1371/journal.pone.0042193 ID - Motsch2012 ER - TY - JOUR AU - Parrales, A. AU - Iwakuma, T. PY - 2015 DA - 2015// TI - Targeting oncogenic mutant p53 for Cancer therapy JO - Front Oncol VL - 5 UR - https://doi.org/10.3389/fonc.2015.00288 DO - 10.3389/fonc.2015.00288 ID - Parrales2015 ER - TY - JOUR AU - Yoshida, G. J. PY - 2015 DA - 2015// TI - Metabolic reprogramming: the emerging concept and associated therapeutic strategies JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0221-y DO - 10.1186/s13046-015-0221-y ID - Yoshida2015 ER - TY - JOUR AU - Yoshida, G. J. PY - 2017 DA - 2017// TI - Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0436-9 DO - 10.1186/s13045-017-0436-9 ID - Yoshida2017 ER - TY - JOUR AU - White, E. PY - 2015 DA - 2015// TI - The role for autophagy in cancer JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/JCI73941 DO - 10.1172/JCI73941 ID - White2015 ER - TY - JOUR AU - Kang, R. AU - Zeh, H. J. AU - Lotze, M. T. AU - Tang, D. PY - 2011 DA - 2011// TI - The Beclin 1 network regulates autophagy and apoptosis JO - Cell Death Differ VL - 18 UR - https://doi.org/10.1038/cdd.2010.191 DO - 10.1038/cdd.2010.191 ID - Kang2011 ER - TY - JOUR AU - Karube, K. AU - Nakagawa, M. AU - Tsuzuki, S. AU - Takeuchi, I. AU - Honma, K. AU - Nakashima, Y. PY - 2011 DA - 2011// TI - Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses JO - Blood. VL - 118 UR - https://doi.org/10.1182/blood-2011-04-346890 DO - 10.1182/blood-2011-04-346890 ID - Karube2011 ER - TY - JOUR AU - Huang, J. J. AU - Li, H. R. AU - Huang, Y. AU - Jiang, W. Q. AU - Xu, R. H. AU - Huang, H. Q. PY - 2010 DA - 2010// TI - Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type JO - Autophagy. VL - 6 UR - https://doi.org/10.4161/auto.6.6.12784 DO - 10.4161/auto.6.6.12784 ID - Huang2010 ER - TY - JOUR AU - Tan, D. AU - Diong, C. P. AU - Loh, Y. AU - Goh, Y. T. PY - 2016 DA - 2016// TI - Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL) JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw231 DO - 10.1093/annonc/mdw231 ID - Tan2016 ER - TY - JOUR AU - Kim, S. J. AU - Kim, J. H. AU - Ki, C. S. AU - Ko, Y. H. AU - Kim, J. S. AU - Kim, W. S. PY - 2016 DA - 2016// TI - Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin JO - Ann Oncol : official journal of the European Society for Medical Oncology VL - 27 UR - https://doi.org/10.1093/annonc/mdv596 DO - 10.1093/annonc/mdv596 ID - Kim2016 ER - TY - JOUR AU - Siu, L. L. AU - Chan, V. AU - Chan, J. K. AU - Wong, K. F. AU - Liang, R. AU - Kwong, Y. L. PY - 2000 DA - 2000// TI - Consistent patterns of allelic loss in natural killer cell lymphoma JO - Am J Pathol VL - 157 UR - https://doi.org/10.1016/S0002-9440(10)64818-3 DO - 10.1016/S0002-9440(10)64818-3 ID - Siu2000 ER - TY - JOUR AU - Siu, L. L. AU - Wong, K. F. AU - Chan, J. K. AU - Kwong, Y. L. PY - 1999 DA - 1999// TI - Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations JO - Am J Pathol VL - 155 UR - https://doi.org/10.1016/S0002-9440(10)65454-5 DO - 10.1016/S0002-9440(10)65454-5 ID - Siu1999 ER - TY - JOUR AU - Sun, L. AU - Li, M. AU - Huang, X. AU - Xu, J. AU - Gao, Z. AU - Liu, C. PY - 2014 DA - 2014// TI - High-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression JO - Med Oncol VL - 31 UR - https://doi.org/10.1007/s12032-014-0071-z DO - 10.1007/s12032-014-0071-z ID - Sun2014 ER - TY - JOUR AU - Küçük, C. AU - Iqbal, J. AU - Hu, X. AU - Gaulard, P. AU - Leval, L. D. AU - Srivastava, G. PY - 2011 DA - 2011// TI - PRDM1 is a tumor suppressor gene in natural killer cell malignancies JO - Proc Natl Acad Sci VL - 108 UR - https://doi.org/10.1073/pnas.1115128108 DO - 10.1073/pnas.1115128108 ID - Küçük2011 ER - TY - JOUR AU - Minnich, M. AU - Tagoh, H. AU - Bonelt, P. AU - Axelsson, E. AU - Fischer, M. AU - Cebolla, B. PY - 2016 DA - 2016// TI - Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation JO - Nat Immunol VL - 17 UR - https://doi.org/10.1038/ni.3349 DO - 10.1038/ni.3349 ID - Minnich2016 ER - TY - JOUR AU - Sciammas, R. AU - Davis, M. M. PY - 2005 DA - 2005// TI - Blimp-1; immunoglobulin secretion and the switch to plasma cells JO - Curr Top Microbiol Immunol VL - 290 ID - Sciammas2005 ER - TY - JOUR AU - Turner, C. A. AU - Mack, D. H. AU - Davis, M. M. PY - 1994 DA - 1994// TI - Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells JO - Cell. VL - 77 UR - https://doi.org/10.1016/0092-8674(94)90321-2 DO - 10.1016/0092-8674(94)90321-2 ID - Turner1994 ER - TY - JOUR AU - Kallies, A. AU - Hawkins, E. D. AU - Belz, G. T. AU - Metcalf, D. AU - Hommel, M. AU - Corcoran, L. M. PY - 2006 DA - 2006// TI - Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance JO - Nat Immunol VL - 7 UR - https://doi.org/10.1038/ni1321 DO - 10.1038/ni1321 ID - Kallies2006 ER - TY - JOUR AU - Martins, G. A. AU - Cimmino, L. AU - Shapiro-Shelef, M. AU - Szabolcs, M. AU - Herron, A. AU - Magnusdottir, E. PY - 2006 DA - 2006// TI - Transcriptional repressor Blimp-1 regulates T cell homeostasis and function JO - Nat Immunol VL - 7 UR - https://doi.org/10.1038/ni1320 DO - 10.1038/ni1320 ID - Martins2006 ER - TY - JOUR AU - Calado, D. P. AU - Zhang, B. AU - Srinivasan, L. AU - Sasaki, Y. AU - Seagal, J. AU - Unitt, C. PY - 2010 DA - 2010// TI - Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma JO - Cancer Cell VL - 18 UR - https://doi.org/10.1016/j.ccr.2010.11.024 DO - 10.1016/j.ccr.2010.11.024 ID - Calado2010 ER - TY - JOUR AU - Mandelbaum, J. AU - Bhagat, G. AU - Tang, H. AU - Mo, T. AU - Brahmachary, M. AU - Shen, Q. PY - 2010 DA - 2010// TI - BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma JO - Cancer Cell VL - 18 UR - https://doi.org/10.1016/j.ccr.2010.10.030 DO - 10.1016/j.ccr.2010.10.030 ID - Mandelbaum2010 ER - TY - JOUR AU - Zhang, Z. AU - Liang, L. AU - Li, D. AU - Nong, L. AU - Liu, J. AU - Qu, L. PY - 2017 DA - 2017// TI - Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation JO - Hematol Oncol VL - 35 UR - https://doi.org/10.1002/hon.2362 DO - 10.1002/hon.2362 ID - Zhang2017 ER - TY - JOUR AU - Baytak, E. AU - Gong, Q. AU - Akman, B. AU - Yuan, H. AU - Chan, W. C. AU - Küçük, C. PY - 2017 DA - 2017// TI - Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1 JO - Tumor Biol VL - 39 UR - https://doi.org/10.1177/1010428317701648 DO - 10.1177/1010428317701648 ID - Baytak2017 ER - TY - JOUR AU - Zou, Y. AU - Tsai, W. -. B. AU - Cheng, C. -. J. AU - Hsu, C. AU - Chung, Y. M. AU - Li, P. -. C. PY - 2008 DA - 2008// TI - Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr1872 DO - 10.1186/bcr1872 ID - Zou2008 ER - TY - JOUR AU - Paik, J. -. H. AU - Kollipara, R. AU - Chu, G. AU - Ji, H. AU - Xiao, Y. AU - Ding, Z. PY - 2007 DA - 2007// TI - FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis JO - Cell. VL - 128 UR - https://doi.org/10.1016/j.cell.2006.12.029 DO - 10.1016/j.cell.2006.12.029 ID - Paik2007 ER - TY - JOUR AU - Karube, K. AU - Tsuzuki, S. AU - Yoshida, N. AU - Arita, K. AU - Liu, F. AU - Kondo, E. PY - 2012 DA - 2012// TI - Lineage-specific growth inhibition of NK cell lines by FOXO3 in association with Akt activation status JO - Exp Hematol VL - 40 UR - https://doi.org/10.1016/j.exphem.2012.08.005 DO - 10.1016/j.exphem.2012.08.005 ID - Karube2012 ER - TY - JOUR AU - Zhang, L. AU - Anglesio, M. S. AU - O'Sullivan, M. AU - Zhang, F. AU - Yang, G. AU - Sarao, R. PY - 2007 DA - 2007// TI - The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1621 DO - 10.1038/nm1621 ID - Zhang2007 ER - TY - JOUR AU - Kucuk, C. AU - Hu, X. AU - Iqbal, J. AU - Gaulard, P. AU - Klinkebiel, D. AU - Cornish, A. PY - 2013 DA - 2013// TI - HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms JO - Am J Pathol VL - 182 UR - https://doi.org/10.1016/j.ajpath.2012.09.012 DO - 10.1016/j.ajpath.2012.09.012 ID - Kucuk2013 ER - TY - JOUR AU - Kurniawan, A. N. AU - Hongyo, T. AU - Hardjolukito, E. S. AU - Ham, M. F. AU - Takakuwa, T. AU - Kodariah, R. PY - 2006 DA - 2006// TI - Gene mutation analysis of sinonasal lymphomas in Indonesia JO - Oncol Rep VL - 15 ID - Kurniawan2006 ER - TY - JOUR AU - Kucuk, C. AU - Hu, X. AU - Jiang, B. AU - Klinkebiel, D. AU - Geng, H. AU - Gong, Q. PY - 2015 DA - 2015// TI - Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma JO - Clin Cancer Res : an official journal of the American Association for Cancer Research VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1216 DO - 10.1158/1078-0432.CCR-14-1216 ID - Kucuk2015 ER - TY - JOUR AU - Siu, L. L. AU - Chan, J. K. AU - Wong, K. F. AU - Kwong, Y. L. PY - 2002 DA - 2002// TI - Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved JO - Am J Pathol VL - 160 UR - https://doi.org/10.1016/S0002-9440(10)64349-0 DO - 10.1016/S0002-9440(10)64349-0 ID - Siu2002 ER - TY - JOUR AU - Paik, J. H. AU - Jang, J. Y. AU - Jeon, Y. K. AU - Kim, W. Y. AU - Kim, T. M. AU - Heo, D. S. PY - 2011 DA - 2011// TI - MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma JO - Clin Cancer Res : an official journal of the American Association for Cancer Research. VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0494 DO - 10.1158/1078-0432.CCR-11-0494 ID - Paik2011 ER - TY - JOUR AU - Sharpe, A. H. PY - 2017 DA - 2017// TI - Introduction to checkpoint inhibitors and cancer immunotherapy JO - Immunol Rev VL - 276 UR - https://doi.org/10.1111/imr.12531 DO - 10.1111/imr.12531 ID - Sharpe2017 ER - TY - JOUR AU - Beatty, G. L. AU - Gladney, W. L. PY - 2015 DA - 2015// TI - Immune escape mechanisms as a guide for cancer immunotherapy JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1860 DO - 10.1158/1078-0432.CCR-14-1860 ID - Beatty2015 ER - TY - JOUR AU - Jo, J. C. AU - Kim, M. AU - Choi, Y. AU - Kim, H. J. AU - Kim, J. E. AU - Chae, S. W. PY - 2017 DA - 2017// TI - Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type JO - Ann Hematol VL - 96 UR - https://doi.org/10.1007/s00277-016-2818-4 DO - 10.1007/s00277-016-2818-4 ID - Jo2017 ER - TY - JOUR AU - Kim, W. Y. AU - Jung, H. Y. AU - Nam, S. J. AU - Kim, T. M. AU - Heo, D. S. AU - Kim, C. W. PY - 2016 DA - 2016// TI - Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis JO - Virchows Arch VL - 469 UR - https://doi.org/10.1007/s00428-016-2011-0 DO - 10.1007/s00428-016-2011-0 ID - Kim2016 ER - TY - JOUR AU - Panjwani, P. K. AU - Charu, V. AU - DeLisser, M. AU - Molina-Kirsch, H. AU - Natkunam, Y. AU - Zhao, S. PY - 2018 DA - 2018// TI - Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes JO - Hum Pathol VL - 71 UR - https://doi.org/10.1016/j.humpath.2017.10.029 DO - 10.1016/j.humpath.2017.10.029 ID - Panjwani2018 ER - TY - JOUR AU - Song, T. L. AU - Nairismagi, M. L. AU - Laurensia, Y. AU - Lim, J. Q. AU - Tan, J. AU - Li, Z. M. PY - 2018 DA - 2018// TI - Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma JO - Blood. VL - 132 UR - https://doi.org/10.1182/blood-2018-01-829424 DO - 10.1182/blood-2018-01-829424 ID - Song2018 ER - TY - JOUR AU - Bi, X. W. AU - Wang, H. AU - Zhang, W. W. AU - Wang, J. H. AU - Liu, W. J. AU - Xia, Z. J. PY - 2016 DA - 2016// TI - PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0341-7 DO - 10.1186/s13045-016-0341-7 ID - Bi2016 ER - TY - JOUR AU - Chan, T. S. Y. AU - Li, J. AU - Loong, F. AU - Khong, P. L. AU - Tse, E. AU - Kwong, Y. L. PY - 2018 DA - 2018// TI - PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing L-asparaginase: efficacy and safety JO - Ann Hematol VL - 97 UR - https://doi.org/10.1007/s00277-017-3127-2 DO - 10.1007/s00277-017-3127-2 ID - Chan2018 ER - TY - JOUR AU - Li, X. AU - Cheng, Y. AU - Zhang, M. AU - Yan, J. AU - Li, L. AU - Fu, X. PY - 2018 DA - 2018// TI - Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0559-7 DO - 10.1186/s13045-018-0559-7 ID - Li2018 ER - TY - JOUR AU - Gibney, G. T. AU - Weiner, L. M. AU - Atkins, M. B. PY - 2016 DA - 2016// TI - Predictive biomarkers for checkpoint inhibitor-based immunotherapy JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30406-5 DO - 10.1016/S1470-2045(16)30406-5 ID - Gibney2016 ER - TY - JOUR AU - Nagato, T. AU - Ohkuri, T. AU - Ohara, K. AU - Hirata, Y. AU - Kishibe, K. AU - Komabayashi, Y. PY - 2017 DA - 2017// TI - Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy JO - Cancer Immunol Immunother VL - 66 UR - https://doi.org/10.1007/s00262-017-1987-x DO - 10.1007/s00262-017-1987-x ID - Nagato2017 ER - TY - JOUR AU - Ng, S. B. AU - Fan, S. AU - Choo, S. N. AU - Hoppe, M. AU - Mai Phuong, H. AU - Mel, S. PY - 2018 DA - 2018// TI - Quantitative analysis of a multiplexed immunofluorescence panel in T-cell lymphoma JO - SLAS Technol VL - 23 ID - Ng2018 ER - TY - JOUR AU - Rickinson, A. B. AU - Moss, D. J. PY - 1997 DA - 1997// TI - Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection JO - Annu Rev Immunol VL - 15 UR - https://doi.org/10.1146/annurev.immunol.15.1.405 DO - 10.1146/annurev.immunol.15.1.405 ID - Rickinson1997 ER - TY - JOUR AU - Kanno, H. AU - Kojya, S. AU - Li, T. AU - Ohsawa, M. AU - Nakatsuka, S. AU - Miyaguchi, M. PY - 2000 DA - 2000// TI - Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology JO - Int J Cancer VL - 87 UR - https://doi.org/3.0.CO;2-0 DO - 3.0.CO;2-0 ID - Kanno2000 ER - TY - JOUR AU - Li, Z. AU - Xia, Y. AU - Feng, L. N. AU - Chen, J. R. AU - Li, H. M. AU - Cui, J. PY - 2016 DA - 2016// TI - Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study JO - Lancet Oncology VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30148-6 DO - 10.1016/S1470-2045(16)30148-6 ID - Li2016 ER - TY - JOUR AU - Reeves, E. AU - James, E. PY - 2017 DA - 2017// TI - Antigen processing and immune regulation in the response to tumours JO - Immunology. VL - 150 UR - https://doi.org/10.1111/imm.12675 DO - 10.1111/imm.12675 ID - Reeves2017 ER - TY - JOUR AU - Bollard, C. M. AU - Gottschalk, S. AU - Torrano, V. AU - Diouf, O. AU - Ku, S. AU - Hazrat, Y. PY - 2014 DA - 2014// TI - Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins JO - J Clin Oncol : official journal of the American Society of Clinical Oncology VL - 32 UR - https://doi.org/10.1200/JCO.2013.51.5304 DO - 10.1200/JCO.2013.51.5304 ID - Bollard2014 ER - TY - JOUR AU - O’Connor, M. J. PY - 2015 DA - 2015// TI - Targeting the DNA damage response in Cancer JO - Mol Cell VL - 60 UR - https://doi.org/10.1016/j.molcel.2015.10.040 DO - 10.1016/j.molcel.2015.10.040 ID - O’Connor2015 ER - TY - JOUR AU - Liu, A. AU - Takakuwa, T. AU - Luo, W. J. AU - Fujita, S. AU - Aozasa, K. PY - 2006 DA - 2006// TI - Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection JO - Cancer Sci VL - 97 UR - https://doi.org/10.1111/j.1349-7006.2006.00226.x DO - 10.1111/j.1349-7006.2006.00226.x ID - Liu2006 ER - TY - JOUR AU - Sui, X. AU - Zhang, C. AU - Zhou, J. AU - Cao, S. AU - Xu, C. AU - Tang, F. PY - 2017 DA - 2017// TI - Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway JO - J Exp Clin Cancer Res VL - 36 UR - https://doi.org/10.1186/s13046-017-0601-6 DO - 10.1186/s13046-017-0601-6 ID - Sui2017 ER - TY - JOUR AU - Cai, Q. AU - Chen, K. AU - Young, K. H. PY - 2015 DA - 2015// TI - Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders JO - Exp Mol Med VL - 47 UR - https://doi.org/10.1038/emm.2014.105 DO - 10.1038/emm.2014.105 ID - Cai2015 ER - TY - JOUR AU - Folkman, J. PY - 1971 DA - 1971// TI - Tumor angiogenesis: therapeutic implications JO - N Engl J Med VL - 285 UR - https://doi.org/10.1056/NEJM197111182852108 DO - 10.1056/NEJM197111182852108 ID - Folkman1971 ER - TY - JOUR AU - Jørgensen, J. M. AU - Sørensen, F. B. AU - Bendix, K. AU - Nielsen, J. L. AU - Funder, A. AU - Karkkainen, M. J. PY - 2009 DA - 2009// TI - Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas JO - Leukemia Lymphoma. VL - 50 UR - https://doi.org/10.1080/10428190903156729 DO - 10.1080/10428190903156729 ID - Jørgensen2009 ER - TY - JOUR AU - Comoglio, P. M. AU - Giordano, S. AU - Trusolino, L. PY - 2008 DA - 2008// TI - Drug development of MET inhibitors: targeting oncogene addiction and expedience JO - Nat Rev Drug Discov VL - 7 UR - https://doi.org/10.1038/nrd2530 DO - 10.1038/nrd2530 ID - Comoglio2008 ER - TY - JOUR AU - Hicklin, D. J. AU - Ellis, L. M. PY - 2005 DA - 2005// TI - Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis JO - J Clinical Oncol : official journal of the American Society of Clinical Oncology. VL - 23 UR - https://doi.org/10.1200/JCO.2005.06.081 DO - 10.1200/JCO.2005.06.081 ID - Hicklin2005 ER - TY - JOUR AU - Ganjoo, K. AU - Hong, F. AU - Horning, S. J. AU - Gascoyne, R. D. AU - Natkunam, Y. AU - Swinnen, L. J. PY - 2014 DA - 2014// TI - Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an eastern cooperative oncology group study (E2404) JO - Leukemia Lymphoma. VL - 55 UR - https://doi.org/10.3109/10428194.2013.816700 DO - 10.3109/10428194.2013.816700 ID - Ganjoo2014 ER - TY - JOUR AU - Ho, F. C. AU - Srivastava, G. AU - Loke, S. L. AU - Fu, K. H. AU - Leung, B. P. AU - Liang, R. PY - 1990 DA - 1990// TI - Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ‘T’ cell type JO - Hematol Oncol VL - 8 UR - https://doi.org/10.1002/hon.2900080505 DO - 10.1002/hon.2900080505 ID - Ho1990 ER - TY - STD TI - Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of Tumours of Haematopoietic and lymphoid tissues. Revised 4th edition ed. Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editor. Lyon: IARC; 2017. ID - ref132 ER - TY - JOUR AU - Chiang, A. K. AU - Tao, Q. AU - Srivastava, G. AU - Ho, F. C. PY - 1996 DA - 1996// TI - Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease JO - Int J Cancer VL - 68 UR - https://doi.org/3.0.CO;2-Y DO - 3.0.CO;2-Y ID - Chiang1996 ER - TY - JOUR AU - Xu, Z. G. AU - Iwatsuki, K. AU - Oyama, N. AU - Ohtsuka, M. AU - Satoh, M. AU - Kikuchi, S. PY - 2001 DA - 2001// TI - The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas JO - Br J Cancer VL - 84 UR - https://doi.org/10.1054/bjoc.2000.1687 DO - 10.1054/bjoc.2000.1687 ID - Xu2001 ER - TY - JOUR AU - Lee, M. A. AU - Diamond, M. E. AU - Yates, J. L. PY - 1999 DA - 1999// TI - Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus JO - J Virol VL - 73 ID - Lee1999 ER - TY - JOUR AU - Humme, S. AU - Reisbach, G. AU - Feederle, R. AU - Delecluse, H. J. AU - Bousset, K. AU - Hammerschmidt, W. PY - 2003 DA - 2003// TI - The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1832776100 DO - 10.1073/pnas.1832776100 ID - Humme2003 ER - TY - JOUR AU - Wang, D. AU - Liebowitz, D. AU - Kieff, E. PY - 1985 DA - 1985// TI - An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells JO - Cell. VL - 43 UR - https://doi.org/10.1016/0092-8674(85)90256-9 DO - 10.1016/0092-8674(85)90256-9 ID - Wang1985 ER - TY - JOUR AU - Kaye, K. M. AU - Izumi, K. M. AU - Kieff, E. PY - 1993 DA - 1993// TI - Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation JO - Proc Natl Acad Sci U S A VL - 90 UR - https://doi.org/10.1073/pnas.90.19.9150 DO - 10.1073/pnas.90.19.9150 ID - Kaye1993 ER - TY - JOUR AU - Young, L. S. AU - Murray, P. G. PY - 2003 DA - 2003// TI - Epstein-Barr virus and oncogenesis: from latent genes to tumours JO - Oncogene. VL - 22 UR - https://doi.org/10.1038/sj.onc.1206556 DO - 10.1038/sj.onc.1206556 ID - Young2003 ER - TY - JOUR AU - Eliopoulos, A. G. AU - Young, L. S. PY - 2001 DA - 2001// TI - LMP1 structure and signal transduction JO - Semin Cancer Biol VL - 11 UR - https://doi.org/10.1006/scbi.2001.0410 DO - 10.1006/scbi.2001.0410 ID - Eliopoulos2001 ER - TY - JOUR AU - Gires, O. AU - Zimber-Strobl, U. AU - Gonnella, R. AU - Ueffing, M. AU - Marschall, G. AU - Zeidler, R. PY - 1997 DA - 1997// TI - Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule JO - EMBO J VL - 16 UR - https://doi.org/10.1093/emboj/16.20.6131 DO - 10.1093/emboj/16.20.6131 ID - Gires1997 ER - TY - JOUR AU - Kilger, E. AU - Kieser, A. AU - Baumann, M. AU - Hammerschmidt, W. PY - 1998 DA - 1998// TI - Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor JO - EMBO J VL - 17 UR - https://doi.org/10.1093/emboj/17.6.1700 DO - 10.1093/emboj/17.6.1700 ID - Kilger1998 ER - TY - JOUR AU - Mosialos, G. AU - Birkenbach, M. AU - Yalamanchili, R. AU - VanArsdale, T. AU - Ware, C. AU - Kieff, E. PY - 1995 DA - 1995// TI - The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family JO - Cell. VL - 80 UR - https://doi.org/10.1016/0092-8674(95)90489-1 DO - 10.1016/0092-8674(95)90489-1 ID - Mosialos1995 ER - TY - JOUR AU - Uchida, J. AU - Yasui, T. AU - Takaoka-Shichijo, Y. AU - Muraoka, M. AU - Kulwichit, W. AU - Raab-Traub, N. PY - 1999 DA - 1999// TI - Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses JO - Science. VL - 286 UR - https://doi.org/10.1126/science.286.5438.300 DO - 10.1126/science.286.5438.300 ID - Uchida1999 ER - TY - JOUR AU - Noguchi, T. AU - Ikeda, K. AU - Yamamoto, K. AU - Yoshida, I. AU - Ashiba, A. AU - Tsuchiyama, J. PY - 2001 DA - 2001// TI - Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells JO - Br J Haematol VL - 114 UR - https://doi.org/10.1046/j.1365-2141.2001.02887.x DO - 10.1046/j.1365-2141.2001.02887.x ID - Noguchi2001 ER - TY - JOUR AU - Takahara, M. AU - Kis, L. L. AU - Nagy, N. AU - Liu, A. AU - Harabuchi, Y. AU - Klein, G. PY - 2006 DA - 2006// TI - Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3 JO - Int J Cancer VL - 119 UR - https://doi.org/10.1002/ijc.22139 DO - 10.1002/ijc.22139 ID - Takahara2006 ER - TY - JOUR AU - Godshalk, S. E. AU - Bhaduri-McIntosh, S. AU - Slack, F. J. PY - 2008 DA - 2008// TI - Epstein-Barr virus-mediated dysregulation of human microRNA expression JO - Cell Cycle VL - 7 UR - https://doi.org/10.4161/cc.7.22.7120 DO - 10.4161/cc.7.22.7120 ID - Godshalk2008 ER - TY - JOUR AU - Gatto, G. AU - Rossi, A. AU - Rossi, D. AU - Kroening, S. AU - Bonatti, S. AU - Mallardo, M. PY - 2008 DA - 2008// TI - Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway JO - Nucleic Acids Res VL - 36 UR - https://doi.org/10.1093/nar/gkn666 DO - 10.1093/nar/gkn666 ID - Gatto2008 ER - TY - JOUR AU - Kenney, J. L. AU - Guinness, M. E. AU - Curiel, T. AU - Lacy, J. PY - 1998 DA - 1998// TI - Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells JO - Blood. VL - 92 ID - Kenney1998 ER - TY - JOUR AU - Cahir-McFarland, E. D. AU - Davidson, D. M. AU - Schauer, S. L. AU - Duong, J. AU - Kieff, E. PY - 2000 DA - 2000// TI - NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.100119497 DO - 10.1073/pnas.100119497 ID - Cahir-McFarland2000 ER - TY - JOUR AU - Malavasi, F. AU - Funaro, A. AU - Roggero, S. AU - Horenstein, A. AU - Calosso, L. AU - Mehta, K. PY - 1994 DA - 1994// TI - Human CD38: a glycoprotein in search of a function JO - Immunol Today VL - 15 UR - https://doi.org/10.1016/0167-5699(94)90148-1 DO - 10.1016/0167-5699(94)90148-1 ID - Malavasi1994 ER - TY - JOUR AU - Wang, L. AU - Wang, H. AU - Li, P. F. AU - Lu, Y. AU - Xia, Z. J. AU - Huang, H. Q. PY - 2015 DA - 2015// TI - CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type JO - Ann Hematol VL - 94 UR - https://doi.org/10.1007/s00277-015-2359-2 DO - 10.1007/s00277-015-2359-2 ID - Wang2015 ER - TY - JOUR AU - Mustafa, N. AU - Nee, H. F. A. AU - Lee, X. T. J. AU - Jin, W. AU - Yu, Y. AU - Chen, Y. PY - 2017 DA - 2017// TI - Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression JO - Blood VL - 130 ID - Mustafa2017 ER - TY - JOUR AU - Hari, P. AU - Raj, R. V. AU - Olteanu, H. PY - 2016 DA - 2016// TI - Targeting CD38 in refractory Extranodal natural killer cell-T-cell lymphoma JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMc1605684 DO - 10.1056/NEJMc1605684 ID - Hari2016 ER - TY - JOUR AU - Abbaspour Babaei, M. AU - Kamalidehghan, B. AU - Saleem, M. AU - Huri, H. Z. AU - Ahmadipour, F. PY - 2016 DA - 2016// TI - Receptor tyrosine kinase (c-kit) inhibitors: a potential therapeutic target in cancer cells JO - Drug Des Devel Ther VL - 10 UR - https://doi.org/10.2147/DDDT.S89114 DO - 10.2147/DDDT.S89114 ID - Abbaspour Babaei2016 ER - TY - JOUR AU - Hongyo, T. AU - Li, T. AU - Syaifudin, M. AU - Baskar, R. AU - Ikeda, H. AU - Kanakura, Y. PY - 2000 DA - 2000// TI - Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan JO - Cancer Res VL - 60 ID - Hongyo2000 ER - TY - JOUR AU - Huynh, K. D. AU - Fischle, W. AU - Verdin, E. AU - Bardwell, V. J. PY - 2000 DA - 2000// TI - BCoR, a novel corepressor involved in BCL-6 repression JO - Genes Dev VL - 14 ID - Huynh2000 ER - TY - JOUR AU - Milne, T. A. AU - Briggs, S. D. AU - Brock, H. W. AU - Martin, M. E. AU - Gibbs, D. AU - Allis, C. D. PY - 2002 DA - 2002// TI - MLL targets SET domain methyltransferase activity to Hox gene promoters JO - Mol Cell VL - 10 UR - https://doi.org/10.1016/S1097-2765(02)00741-4 DO - 10.1016/S1097-2765(02)00741-4 ID - Milne2002 ER - TY - JOUR AU - Dobashi, A. AU - Tsuyama, N. AU - Asaka, R. AU - Togashi, Y. AU - Ueda, K. AU - Sakata, S. PY - 2016 DA - 2016// TI - Frequent BCOR aberrations in extranodal NK/T-cell lymphoma, nasal type JO - Genes, Chromosomes Cancer VL - 55 UR - https://doi.org/10.1002/gcc.22348 DO - 10.1002/gcc.22348 ID - Dobashi2016 ER - TY - JOUR AU - Jaccard, A. AU - Hermine, O. PY - 2017 DA - 2017// TI - A major turning point in NK/T-cell lymphoma? JO - Blood. VL - 129 UR - https://doi.org/10.1182/blood-2017-03-769075 DO - 10.1182/blood-2017-03-769075 ID - Jaccard2017 ER - TY - JOUR AU - Burr, M. L. AU - Sparbier, C. E. AU - Chan, Y. C. AU - Williamson, J. C. AU - Woods, K. AU - Beavis, P. A. PY - 2017 DA - 2017// TI - CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity JO - Nature. VL - 549 UR - https://doi.org/10.1038/nature23643 DO - 10.1038/nature23643 ID - Burr2017 ER - TY - STD TI - de Mel S, Soon GS, Mok Y, Chung TH, Jeyasekharan AD, Chng WJ, Ng SB. The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation. Int J Mol Sci. 2018;19(7). ID - ref162 ER - TY - JOUR AU - Aster, J. C. AU - Blacklow, S. C. AU - Pear, W. S. PY - 2011 DA - 2011// TI - Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies JO - J Pathol VL - 223 UR - https://doi.org/10.1002/path.2789 DO - 10.1002/path.2789 ID - Aster2011 ER - TY - JOUR AU - Zhang, Y. AU - Ohyashiki, J. H. AU - Takaku, T. AU - Shimizu, N. AU - Ohyashiki, K. PY - 2006 DA - 2006// TI - Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6602968 DO - 10.1038/sj.bjc.6602968 ID - Zhang2006 ER - TY - JOUR AU - Ng, S. B. AU - Ohshima, K. AU - Selvarajan, V. AU - Huang, G. AU - Choo, S. N. AU - Miyoshi, H. AU - Shimizu, N. AU - Reghunathan, R. AU - Chua, H. C. AU - Yeoh, A. E. AU - Quah, T. C. AU - Koh, L. P. AU - Tan, P. L. AU - Chng, W. J. PY - 2015 DA - 2015// TI - Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.983099 DO - 10.3109/10428194.2014.983099 ID - Ng2015 ER - TY - JOUR AU - Guo, H. Q. AU - Huang, G. L. AU - Guo, C. C. AU - Pu, X. X. AU - Lin, T. Y. PY - 2010 DA - 2010// TI - Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma JO - Dis Markers VL - 29 UR - https://doi.org/10.1155/2010/474692 DO - 10.1155/2010/474692 ID - Guo2010 ER - TY - STD TI - Hu B, Oki Y. Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma. Front Oncol. 2018;8(139). ID - ref167 ER -